Abstract
- Population: 9-16 year-old seropositive individuals living in dengue endemic areas
- Intervention: 3 doses of CYD-TDV administered 6 months apart
- Comparison: Placebo
- Outcome: Serious adverse events (non-dengue)
GRADE table
Dengue
